Intersect Diagnostics

Developer of novel biomarker signatures intended to be used in precision therapeutics. The company's technology is used in designing, optimizing, validating, and deploying proprietary assays on new drug development instruments, enabling medical research institutes to advance novel therapies toward regulatory approval.